Camurus AB (OTCPK:CAMRF)
$ 54 -2 (-3.57%) Market Cap: 3.35 Bil Enterprise Value: 2.96 Bil PE Ratio: 45.77 PB Ratio: 6.98 GF Score: 79/100

Q1 2026 Camurus AB Earnings Call Transcript

May 12, 2026 / 12:00 PM GMT
Release Date Price: $63.3

Key Points

Positve
  • Camurus AB (CAMRF) reported a 15% sequential increase in total revenues, reaching 533 million SEK.
  • The company maintained a strong operating margin of 32% and ended the quarter with a robust cash position of 3.9 billion SEK.
  • Significant in-market growth was observed, with VIVRA growing 17% and OxyESA achieving 4 million SEK in net sales in Germany.
  • Rigsadi royalties increased by 44% year-on-year, or 59% at constant exchange rates, indicating strong performance in the US market.
  • The FDA accepted the Auclase NDA in the US, with an anticipated decision date in June, signaling potential future growth.
Negative
  • Total revenues decreased by 5% year-on-year, primarily due to unfavorable currency effects and channel spacing.
  • Reported price sales were down 12% year-on-year, or 6% at constant exchange rates, indicating challenges in pricing strategy.
  • Operating results for the quarter were down 30% compared to the same period last year, highlighting profitability challenges.
  • Marketing and distribution costs increased significantly, driven by expansion efforts and entry into the US market.
  • The UK market faced funding restraints, impacting sales, although a new three-year budget for the NHS was announced.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CAMX.ST - Camurus AB
Q1 2026 Camurus AB Earnings Call
May 12, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to Camilio's Q1 Report 2026. During the questions and answer session, Telco participants are able to ask questions by dialing pound key five on the telephone keypad. Now I will hand the conference over to CEO Jake Tiepai. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you so much, Einar. Good day, everyone, and welcome to our first earnings call in 2026.

Please note first our forward-looking statements.

Here is the agenda for today. I'll start with the highlights. Anders will cover the financials, Richard, the commercial update, and I will return
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot